Orexigen Therapeutics , Nasdaq: OREX
Developing drugs for the treatment of obesity.
Industry: Health Care
First Day Return: +8.3%
OREX
Developing drugs for the treatment of obesity.
| IPO Data | |
|---|---|
| IPO Date | 04/25/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $84 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 2002 |
| Employees at IPO | 23 |
| Website www.orexigen.com | |
IPO News for Orexigen Therapeutics
Orexigen Therapeutics (OREX) Performance
